Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheffler

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
International Angiology : a Journal of the International Union of Angiology|July 1, 1988
Thrombus formation in deep venous thrombosis. A clinical approach to diagnosis and control of lysis efficacyP Scheffler, G Leipnitz, B Braun, et al.
Blut|June 1, 1985
Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnoverM Köhler, P Hellstern, E Morgenstern, et al.
VASA. Supplementum|January 1, 1991
[Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease]W Hepp, S von Bary, D Corovic, et al.
Schweizerische Medizinische Wochenschrift|October 6, 1990
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative]F E Brock, O Abri, G Baitsch, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Thrombolytic therapy with ultra-high doses of streptokinase]M Köhler, P Doenecke, P Hellstern, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Journal of Vascular Surgery|March 1, 1997
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trialC Diehm, K Balzer, H Bisler, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
International Angiology : a Journal of the International Union of Angiology|July 1, 1988
Thrombus formation in deep venous thrombosis. A clinical approach to diagnosis and control of lysis efficacyP Scheffler, G Leipnitz, B Braun, et al.
Blut|June 1, 1985
Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnoverM Köhler, P Hellstern, E Morgenstern, et al.
VASA. Supplementum|January 1, 1991
[Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease]W Hepp, S von Bary, D Corovic, et al.
Schweizerische Medizinische Wochenschrift|October 6, 1990
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative]F E Brock, O Abri, G Baitsch, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Thrombolytic therapy with ultra-high doses of streptokinase]M Köhler, P Doenecke, P Hellstern, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Journal of Vascular Surgery|March 1, 1997
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trialC Diehm, K Balzer, H Bisler, et al.
Pageof 5